Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Vorinostat × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lung Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 108 Lenalidomide 73 daratumumab 59 Bortezomib 49 pomalidomide 40 carfilzomib 39 Calcium Dobesilate 38 Cyclophosphamide 27 Specimen Handling 25 Biopsy 23 talquetamab 19 isatuximab 19 Magnetic Resonance Spectroscopy 19 fludarabine 17 iberdomide 15 dexamethasone acetate 14 dexamethasone 21-phosphate 14 belantamab mafodotin 14 auricularum 14 selinexor 13 elotuzumab 10 tocilizumab 9 fludarabine phosphate 8 trametinib 6 ixazomib 6 X-Rays 6 Melphalan 6 venetoclax 5 Whole-Body Irradiation 5 nirogacestat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01297764 2026-02-19

QUAD

Hackensack Meridian Health

Phase 1/2 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡